PARP1 and cancer: When inoculated to homogenic mice model, PARP upregulated PD-L1 on the surface of EMT6 cancer cells (TNBC cell line) both in vitro and in vivo, which was mediated by inactive GSK3β pathway and induced TIL to decrease.